Biotecnología

Biotecnología

TriLink Invests in New RNA Innovation Center at Johns Hopkins
14/05/2024 - Will accelerate transformational research in RNA therapeutics and discovery.
MiLaboratories, Miltenyi Biotec Enter Genomics Alliance
02/05/2024 - Combines MiLaboratories' RNA kit technology for immune sequencing with Miltenyi Biotec's production and commercialization capabilities.
Ipsen and Skyhawk Therapeutics Collaborate on RNA Targeting Research
25/04/2024 - Aim to discover and develop small molecules for the treatment of rare neurological diseases.
Charles River & Axovia Partner to Support Development of Gene Therapies for Ciliopathies
10/04/2024 - Axovia will leverage Charles River’s plasmid platform and expertise in plasmid DNA production to accelerate time to clinic.
Ship of Theseus Taps Charles River as Manufacturing Partner
08/04/2024 - Charles River to support the development of novel HOX-based therapies through plasmid DNA manufacturing.
Exothera Launches Nucleic Acids Service Offering Powered by Ntensify
27/03/2024 - Continuous batch production of RNA service significantly cuts clinical development time while enhancing quality and yield.
Polyplus Receives GMP Certification for Recombinant Protein & DNA Production
07/03/2024 - Also adds an additional GMP clean room for the production of GMP cell banks.
Ginkgo Bioworks Acquires Patch Biosciences
29/02/2024 - Strengthens its Gene Therapy Services, Cell Therapy Services, and RNA Therapeutics Services.
Entos Pharma Launches GMP Clinical Mfg. Facility in Carlsbad
30/01/2024 - Will manufacture genetic medicines based on Entos Fusogenix PLV platform, including recombinant protein, mRNA, and plasmid DNA.
Almac Sciences Extends selectAZyme Offering
25/01/2024 - Kit contains focussed library of 10 double stranded RNA Ligase enzymes selected from an extended RNAL enzyme panel.
GSK Licenses Elegen’s Cell-Free DNA Mfg. Technology
25/01/2024 - Has potential to enable a seamless transition from discovery to clinical scale-up under GMP.
AGC Biologics to Open New Manufacturing Site in Japan
19/01/2024 - Will offer preclinical through commercial services for mammalian-based protein biologics, cell therapies, and messenger RNA.
CordenPharma, pHLIP Partner on RNA & Gene Therapies
19/01/2024 - Aims to develop and manufacture small molecule drug payloads directly conjugated with (pHLIP) peptides.
Remix, Roche Enter Small Molecule RNA Processing Pact
04/01/2024 - To develop small molecules that modulate RNA processing using Remix's REMaster drug discovery platform.
Depixus, Daiichi Sankyo Partner on MAGNA Technology
13/12/2023 - Daiichi will use MAGNA to explore the interactions of lead molecules with a number of undisclosed RNA targets.
Ardena's New Aseptic Fill-Finish Plant Granted GMP License
01/12/2023 - Has capacity for large molecule biologics, including proteins, next to oligonucleotides (DNA, recombinant RNA, synthetic RNA, RNA vaccines) and peptides.
Charles River, GC4K Enter Gene Therapy Mfg. Pact
29/11/2023 - Will leverage Charles River’s plasmid platform, eXpDNA, and premier expertise in plasmid DNA production.
Altamira Spins-Off Part of its Bentrio Business
22/11/2023 - Initiates strategic repositioning to focus on company’s core RNA delivery technology.
Twist Bioscience Launches Express Genes Rapid Gene Synthesis Service
17/11/2023 - Twist leverages its ability to miniaturize the chemical reaction to creating DNA using its silicon-based DNA synthesis platform.
GenScript, NuclixBio Partner on Circular RNA Therapeutics
13/11/2023 - Establishes first large-scale production process for circular RNA therapeutics from preclinical to clinical stages with GMP production.